Apogenix
PrivateLast Round
Liquidation
Dec 31, 2025
Total Funding Raised
$115.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Apogenix is a biopharmaceutical company that develops novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apogenix Comparables
Compare Apogenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CANbridge Pharma | 74% | |
| AbbVie | 70% | |
| Anaveon | 61% | |
Apogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Liquidation | Dec 31, 2025 | ||||
| Grant | Dec 9, 2021 | ||||
| Grant | Feb 16, 2016 | ||||
| Grant | Jan 3, 2012 | ||||
| Grant | Jul 29, 2009 | ||||
Grant | Sep 19, 2008 |
Apogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | Seed, Corporate Funding, Series B, Grant |
| Bundesregierung | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2025
Company has raised a liquidation round.
- Dec 9, 2021
$29.15M round led by dievini Hopp BioTech holding.
Apogenix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apogenix's valuation, stock price, and market status.